Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ISRCTN22446424) titled 'IIH-Advance: A randomised clinical trial to determine the effects of weight loss, induced by a weight loss drug (Tirzepatide), in adults with active idiopathic intracranial hypertension' on Jan. 19.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Open (masking not used)
Control: Active
Assignment: Parallel
Purpose: Health services research, Supportive care, Treatment
Primary Sponsor: University of Birmingham
Condition:
Idiopathic intracranial hypertension
Circulatory System
Intervention:
Design Overview
IIH-Advance is a phase III, multi-stage, randomised controlled t...